Biotech CEO, two associates accused of securities fraud

(Reuters) — The chief executive of a biotech company that said it was developing a non-opiate pain treatment was arrested along with two associates on Tuesday on U.S. charges that he misled investors and participated in a stock manipulation scheme.

from Business Insurance https://ift.tt/2HPtOgV